Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Sanara MedTech (SMTI) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Sanara MedTech (SMTI) over the last 13 years, with Q3 2025 value amounting to 0.07%.

  • Sanara MedTech's Return on Capital Employed fell 100.0% to 0.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.07%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.1% for FY2024, which is 200.0% down from last year.
  • Sanara MedTech's Return on Capital Employed amounted to 0.07% in Q3 2025, which was down 100.0% from 0.09% recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Return on Capital Employed ranged from a high of 0.06% in Q3 2024 and a low of 0.34% during Q2 2022
  • Its 5-year average for Return on Capital Employed is 0.16%, with a median of 0.13% in 2024.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 7000bps in 2021, then plummeted by -2200bps in 2022.
  • Sanara MedTech's Return on Capital Employed (Quarter) stood at 0.24% in 2021, then fell by -9bps to 0.26% in 2022, then soared by 73bps to 0.07% in 2023, then crashed by -83bps to 0.13% in 2024, then soared by 44bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q3 2025, 0.09% for Q2 2025, and 0.13% during Q1 2025.